Advertisement

Topics

Medivation, Inc. Company Profile

10:34 EST 15th November 2018 | BioPortfolio

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop and commercialize dimebon (latrepirdine) for the treatment of Alzheimer's and Huntington diseases. With Pfizer, Medivation is conducting a clinical development program that includes CONCERT, a Phase 3 trial assessing dimebon in patients with mild-to-moderate Alzheimer's disease, and HORIZON, a Phase 3 trial of dimebon in Huntington disease. In October 2009, Medivation entered into a global agreement with Astellas Pharma Inc. to develop and commercialize MDV3100 for both early- and late-stage prostate cancer. The first Phase 3 clinical trial in the MDV3100 development program, known as the AFFIRM trial, is under way in patients with castration-resistant prostate cancer who have previously been treated with docetaxel-based chemotherapy. Additional trials in earlier-stage prostate cancer will begin in 2010. For more information, please visit us at www.medivation.com.


News Articles [7 Associated News Articles listed on BioPortfolio]

Medivation opens books to Sanofi

Dimebon Study, PTV News: Mar 04, 2010

Medivation and Pfizer Phase III trial fails to meet endpoints

News Headlines , PTV News: Mar 04, 2010

A look at today's forthcoming news stories including the US$ 400M Bristol-Myers Squibb/Allergan deal, disappointment for Medivation's Alzheimier's drug, and Deals in a Downturn part 3

An early approval puts Pfizer's Talzenna in a crowded field

Pfizer picked up the PARP inhibitor in its $14 billion deal for Medivation two years ago. Talzenna will join three other drugs on market that work similarly.

Pfizer Expands In Breast Cancer With Talazoparib Approval

The PARP inhibitor, acquired with Medivation, will launch in a field where Pfizer already has commercial experience through its CDK4/6...   

Medivation Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryMedivation Inc Medivation, a subsidiary of Pfizer is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company's produc...

Medivation Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryMedivation Inc Medivation, a subsidiary of Pfizer is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company's produc...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to provide access to continued treatment for subjects who are currently participating in an enzalutamide clinical study sponsored by Astellas or Medivation for...

Companies [2 Associated Companies listed on BioPortfolio]

Medivation, Inc.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims...

ACT-AD Coalition

ACT-AD is a growing coalition of more than 50 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers and employers seeking to accelerate developme...

More Information about "Medivation, Inc." on BioPortfolio

We have published hundreds of Medivation, Inc. news stories on BioPortfolio along with dozens of Medivation, Inc. Clinical Trials and PubMed Articles about Medivation, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medivation, Inc. Companies in our database. You can also find out about relevant Medivation, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record